Zentalis Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ZNTL and other ETFs, options, and stocks.

About ZNTL

Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing clinically differentiated, novel small molecule therapeutics targeting fundamental biological pathways of cancer. It develops a broad pipeline of product candidates with an initial focus on validated oncology targets with the potential to address large patient populations. 

CEO
Kimberly L. Blackwell
CEOKimberly L. Blackwell
Employees
168
Employees168
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2014
Founded2014
Employees
168
Employees168

ZNTL Key Statistics

Market cap
984.93M
Market cap984.93M
Price-Earnings ratio
-3.04
Price-Earnings ratio-3.04
Dividend yield
Dividend yield
Average volume
1.15M
Average volume1.15M
High today
$14.26
High today$14.26
Low today
$13.70
Low today$13.70
Open price
$14.25
Open price$14.25
Volume
690.20K
Volume690.20K
52 Week high
$31.46
52 Week high$31.46
52 Week low
$9.56
52 Week low$9.56

Analyst ratings

80%

of 10 ratings
Buy
80%
Hold
20%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.